A novel paracetamol 1,000 mg sustained release formulation vs conventional paracetamol 500 mg formulation in patients with fever and pain: a randomized noninferiority trial.
Faculty Articles
Part of the Medicine and Health Sciences Commons
Part of the Medicine and Health Sciences Commons